​

Colgate-Palmolive Company (CL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CL Stock Forecast

Colgate-Palmolive Company stock forecast is as follows: an average price target of $108.67 (represents a 16.95% upside from CL’s last price of $92.92) and a rating consensus of 'Buy', based on 19 wall street analysts offering a 1-year stock forecast.

CL Price Target

The average price target for Colgate-Palmolive Company (CL) is $108.67 based on 1-year price targets from 19 Wall Street analysts in the past 3 months, with a price target range of $121.00 to $100.00. This represents a potential 16.95% upside from CL's last price of $92.92.

CL Analyst Ratings

Buy

According to 19 Wall Street analysts, Colgate-Palmolive Company's rating consensus is 'Buy'. The analyst rating breakdown for CL stock is 0 'Strong Buy' (0.00%), 12 'Buy' (63.16%), 6 'Hold' (31.58%), 1 'Sell' (5.26%), and 0 'Strong Sell' (0.00%).

Colgate-Palmolive Company Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 23, 2024Korinne WolfmeyerPiper Sandler$121.00$103.3117.12%30.22%
Sep 16, 2024Chris CareyWells Fargo$100.00$105.73-5.42%7.62%
Jul 22, 2024Mark AstrachanStifel Nicolaus$105.00$98.087.06%13.00%
May 28, 2024Dara MohsenianMorgan Stanley$103.00$93.3010.40%10.85%
May 15, 2024Chris GrajaArgus Research$107.00$94.5713.14%15.15%
Apr 29, 2024Steve PowersDeutsche Bank$98.00$90.138.74%5.47%
Apr 29, 2024Mark AstrachanStifel Nicolaus$95.00$91.014.38%2.24%
Apr 10, 2024Mark AstrachanStifel Nicolaus$94.00$87.657.24%1.16%
Apr 08, 2024Robert OttensteinEvercore ISI$96.00$87.889.24%3.31%
Jan 29, 2024Olivia TongRaymond James$91.00$83.728.69%-2.07%
Jul 28, 2023Chris CaseyWells Fargo$81.00$75.627.11%-12.83%
Jan 13, 2023J.P. Morgan$86.00$77.6110.81%-7.45%
Jan 03, 2023Barclays$80.00$78.022.54%-13.90%
Dec 06, 2022Deutsche Bank$87.00$77.0512.91%-6.37%
Oct 18, 2022Kaumil GajrawalaCredit Suisse$85.00$72.8216.73%-8.52%
Oct 03, 2022Wells Fargo$75.00$70.256.76%-19.29%
Aug 08, 2022Chris CareyWells Fargo$80.00$80.43-0.53%-13.90%
Aug 02, 2022Barclays$74.00$81.10-8.75%-20.36%
Aug 01, 2022UBS$90.00$80.2212.18%-3.14%
Jul 21, 2022J.P. Morgan$78.00$75.523.28%-16.06%
May 23, 2022Barclays$71.00$75.13-5.50%-23.59%
May 03, 2022Barclays$77.00$75.182.42%-17.13%
May 03, 2022Atlantic Equities$80.00$75.186.41%-13.90%
May 02, 2022Deutsche Bank$88.00$75.3716.76%-5.29%
May 02, 2022Morgan Stanley$82.00$77.066.41%-11.75%
Apr 30, 2022Andrea Faria TeixeiraJ.P. Morgan$79.00$77.052.53%-14.98%
Apr 03, 2022Jason EnglishGoldman Sachs$95.00$76.4224.31%2.24%
Jan 31, 2022Kaumil GajrawalaCredit Suisse$90.00$82.459.16%-3.14%
Jan 31, 2022Wendy NicholsonCitigroup$86.00$82.454.31%-7.45%
Jan 31, 2022Christopher CareyWells Fargo$76.00$82.45-7.82%-18.21%
Jan 05, 2022Kevin GrundyJefferies$89.00$84.765.00%-4.22%
Oct 05, 2021Bryan SpillaneBank of America Securities$80.00$73.578.74%-13.90%
Oct 05, 2021Peter GromUBS$89.00$73.5720.97%-4.22%
Aug 02, 2021Mark AstrachanStifel Nicolaus$88.00$78.6311.92%-5.29%

The latest Colgate-Palmolive Company stock forecast, released on Sep 23, 2024 by Korinne Wolfmeyer from Piper Sandler, set a price target of $121.00, which represents a 17.12% increase from the stock price at the time of the forecast ($103.31), and a 30.22% increase from CL last price ($92.92).

Colgate-Palmolive Company Price Target by Period

1M3M12M
# Anlaysts-110
Avg Price Target-$121.00$101.00
Last Closing Price$92.92$92.92$92.92
Upside/Downside-100.00%30.22%8.70%

In the current month, the average price target of Colgate-Palmolive Company stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Colgate-Palmolive Company's last price of $92.92. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 28, 2024Cowen & Co.BuyBuyHold
Sep 23, 2024Piper SandlerOverweightInitialise
Sep 16, 2024Wells FargoEqual-WeightUnderweightDowngrade
Sep 09, 2024Deutsche BankBuyHoldDowngrade
Jul 29, 2024Cowen & Co.BuyBuyHold
Jul 29, 2024Morgan StanleyOverweightOverweightHold
Jul 26, 2024HSBCHoldDowngrade
Jul 24, 2024JefferiesHoldDowngrade
Jul 22, 2024Cowen & Co.BuyInitialise
Jul 19, 2024BarclaysEqual-WeightEqual-WeightHold
Jul 18, 2024Evercore ISIOutperformOutperformHold
Jul 17, 2024Deutsche BankBuyBuyHold
Jul 10, 2024CitigroupBuyBuyHold
Jun 24, 2024Exane BNP ParibasOutperformInitialise
May 28, 2024Morgan StanleyOverweightOverweightHold
Apr 29, 2024Deutsche BankBuyBuyHold
Apr 29, 2024RBC CapitalSector PerformSector PerformHold
Apr 29, 2024Bank of America SecuritiesBuyBuyHold
Apr 16, 2024CitigroupBuyBuyHold
Apr 12, 2024BarclaysEqual-WeightEqual-WeightHold
Apr 08, 2024Evercore ISIOutperformOutperformHold
Mar 21, 2024CFRABuyUpgrade
Jan 29, 2024UBSBuyBuyHold
Jan 29, 2024Wells FargoEqual-WeightEqual-WeightHold
Jan 29, 2024Raymond JamesOutperformUpgrade
Oct 16, 2023Wells FargoEqual-WeightBuyUpgrade
Jul 28, 2023Deutsche BankBuyBuyHold
Jul 28, 2023Goldman SachsBuyBuyHold
Jul 28, 2023Wells FargoEqual-WeightEqual-WeightHold
Jul 28, 2023Morgan StanleyOverweightOverweightHold
Jan 03, 2023Wells FargoEqual-WeightEqual-WeightHold
Jan 03, 2023BarclaysEqual-WeightEqual-WeightHold
Dec 06, 2022Deutsche BankBuyBuyHold
Oct 18, 2022Credit SuisseOutperformOutperformHold
Oct 18, 2022Deutsche BankBuyBuyHold
Oct 03, 2022Wells FargoEqual-WeightEqual-WeightHold
Aug 02, 2022BarclaysEqual-WeightEqual-WeightHold
Aug 01, 2022Wells FargoEqual-WeightNegativeUpgrade
Aug 01, 2022UBSBuyBuyHold
Aug 01, 2022Wells FargoEqual-WeightUpgrade
May 23, 2022BarclaysEqual-WeightEqual-WeightHold
May 03, 2022Atlantic EquitiesNeutralDowngrade
May 02, 2022Deutsche BankBuyBuyHold
May 02, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Apr 03, 2022Goldman SachsBuyBuyHold

Colgate-Palmolive Company's last stock rating was published by Cowen & Co. on Oct 28, 2024. The company gave CL a "Buy" rating, the same as its previous rate.

Colgate-Palmolive Company Financial Forecast

Colgate-Palmolive Company Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$4.92B$4.82B$4.77B$4.63B$4.46B$4.48B$4.40B$4.40B$4.41B$4.26B$4.34B$4.32B$4.15B$3.90B$4.10B$4.01B$3.93B
Avg Forecast$5.46B$5.40B$5.37B$5.32B$5.25B$5.19B$5.16B$5.14B$5.03B$5.01B$5.00B$4.96B$4.89B$4.81B$4.70B$4.59B$4.59B$4.47B$4.35B$4.40B$4.42B$4.40B$4.25B$4.26B$4.15B$3.99B$3.78B$4.08B$3.93B$3.95B
High Forecast$5.58B$5.51B$5.48B$5.44B$5.36B$5.30B$5.27B$5.24B$5.08B$5.01B$5.00B$4.96B$4.96B$5.00B$4.80B$4.68B$4.69B$4.47B$4.35B$4.40B$4.42B$4.40B$4.25B$4.26B$4.15B$3.99B$3.78B$4.08B$3.93B$3.95B
Low Forecast$5.34B$5.28B$5.25B$5.21B$5.14B$5.08B$5.05B$5.06B$4.97B$5.00B$5.00B$4.96B$4.80B$4.72B$4.59B$4.49B$4.49B$4.47B$4.35B$4.40B$4.42B$4.40B$4.25B$4.26B$4.15B$3.99B$3.78B$4.08B$3.93B$3.95B
# Analysts64464379115347115954475510759991313
Surprise %-------------1.02%1.03%1.04%1.01%1.00%1.03%1.00%1.00%1.00%1.00%1.02%1.04%1.04%1.03%1.01%1.02%1.00%

Colgate-Palmolive Company's average Quarter revenue forecast for Dec 23 based on 7 analysts is $4.89B, with a low forecast of $4.80B, and a high forecast of $4.96B. CL's average Quarter revenue forecast represents a -0.44% decrease compared to the company's last Quarter revenue of $4.92B (Sep 23).

Colgate-Palmolive Company EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts64464379115347115954475510759991313
EBITDA-------------$1.03B$974.00M$1.04B$1.78B$947.00M$1.02B$998.00M$426.00M$946.00M$1.05B$1.05B$988.00M$1.05B$984.00M$995.00M$964.00M$875.00M
Avg Forecast$1.34B$1.32B$1.32B$1.31B$1.29B$1.27B$1.27B$1.26B$1.24B$1.23B$1.23B$1.04B$1.20B$1.18B$1.15B$948.20M$468.60M$1.19B$1.16B$862.00M$1.17B$1.17B$1.13B$1.03B$1.10B$1.06B$1.01B$981.55M$1.05B$1.05B
High Forecast$1.37B$1.35B$1.34B$1.33B$1.32B$1.30B$1.29B$1.28B$1.25B$1.23B$1.23B$1.25B$1.22B$1.23B$1.18B$1.14B$562.32M$1.19B$1.16B$1.03B$1.17B$1.17B$1.13B$1.24B$1.10B$1.06B$1.01B$1.18B$1.05B$1.05B
Low Forecast$1.31B$1.29B$1.29B$1.28B$1.26B$1.25B$1.24B$1.24B$1.22B$1.23B$1.23B$834.42M$1.18B$1.16B$1.13B$758.56M$374.88M$1.19B$1.16B$689.60M$1.17B$1.17B$1.13B$827.00M$1.10B$1.06B$1.01B$785.24M$1.05B$1.05B
Surprise %-------------0.87%0.85%1.09%3.80%0.80%0.88%1.16%0.36%0.81%0.93%1.01%0.90%0.99%0.98%1.01%0.92%0.83%

7 analysts predict CL's average Quarter EBITDA for Dec 23 to be $1.20B, with a high of $1.22B and a low of $1.18B. This is 16.67% upper than Colgate-Palmolive Company's previous annual EBITDA (Sep 23) of $1.03B.

Colgate-Palmolive Company Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts64464379115347115954475510759991313
Net Income-------------$708.00M$502.00M$372.00M$43.00M$618.00M$603.00M$559.00M$188.00M$634.00M$703.00M$681.00M$647.00M$698.00M$635.00M$715.00M$643.00M$578.00M
Avg Forecast$868.15M$844.74M$864.08M$825.89M$814.60M$784.41M$806.33M$765.91M$739.39M$728.04M$714.56M$676.39M$700.42M$659.50M$613.42M$614.90M$162.80M$603.06M$584.45M$559.00M$647.92M$655.15M$658.07M$672.38M$629.86M$578.75M$572.87M$705.34M$598.07M$577.15M
High Forecast$891.87M$867.82M$887.68M$848.45M$836.85M$805.84M$828.36M$790.36M$755.83M$728.50M$714.65M$811.67M$716.90M$675.99M$630.18M$737.88M$195.36M$603.06M$584.45M$670.80M$647.92M$655.15M$658.07M$806.86M$629.86M$578.75M$572.87M$846.41M$598.07M$577.15M
Low Forecast$843.52M$820.78M$839.57M$802.46M$791.49M$762.16M$783.46M$749.62M$722.96M$727.57M$714.46M$541.11M$692.17M$643.01M$596.02M$491.92M$130.24M$603.06M$584.45M$447.20M$647.92M$655.15M$658.07M$537.90M$629.86M$578.75M$572.87M$564.27M$598.07M$577.15M
Surprise %-------------1.07%0.82%0.60%0.26%1.02%1.03%1.00%0.29%0.97%1.07%1.01%1.03%1.21%1.11%1.01%1.08%1.00%

Colgate-Palmolive Company's average Quarter net income forecast for Dec 23 is $700.42M, with a range of $692.17M to $716.90M. CL's average Quarter net income forecast represents a -1.07% decrease compared to the company's last Quarter net income of $708.00M (Sep 23).

Colgate-Palmolive Company SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts64464379115347115954475510759991313
SG&A-------------$1.82B$1.77B$1.76B$1.63B$1.63B$1.66B$1.64B$1.60B$1.64B$1.57B$1.60B$1.63B$1.52B$1.40B$1.47B$1.41B$1.43B
Avg Forecast$1.99B$1.97B$1.96B$1.94B$1.92B$1.90B$1.88B$1.88B$1.84B$1.83B$1.83B$1.99B$1.79B$1.76B$1.72B$1.81B$1.76B$1.61B$1.57B$1.64B$1.59B$1.59B$1.53B$1.58B$1.50B$1.44B$1.36B$1.45B$1.42B$1.42B
High Forecast$2.04B$2.01B$2.00B$1.98B$1.96B$1.94B$1.92B$1.91B$1.86B$1.83B$1.83B$2.38B$1.81B$1.82B$1.75B$2.17B$2.11B$1.61B$1.57B$1.97B$1.59B$1.59B$1.53B$1.90B$1.50B$1.44B$1.36B$1.74B$1.42B$1.42B
Low Forecast$1.95B$1.93B$1.92B$1.90B$1.88B$1.86B$1.84B$1.85B$1.82B$1.83B$1.83B$1.59B$1.75B$1.72B$1.68B$1.44B$1.41B$1.61B$1.57B$1.31B$1.59B$1.59B$1.53B$1.27B$1.50B$1.44B$1.36B$1.16B$1.42B$1.42B
Surprise %-------------1.04%1.03%0.97%0.93%1.01%1.06%1.00%1.00%1.03%1.02%1.01%1.09%1.06%1.02%1.01%1.00%1.00%

Colgate-Palmolive Company's average Quarter SG&A projection for Dec 23 is $1.79B, based on 7 Wall Street analysts, with a range of $1.75B to $1.81B. The forecast indicates a -1.93% fall compared to CL last annual SG&A of $1.82B (Sep 23).

Colgate-Palmolive Company EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts64464379115347115954475510759991313
EPS-------------$0.86$0.61$0.45$0.05$0.74$0.72$0.67$0.22$0.75$0.83$0.80$0.76$0.81$0.74$0.83$0.75$0.67
Avg Forecast$1.06$1.03$1.05$1.00$0.99$0.95$0.98$0.93$0.90$0.89$0.87$0.81$0.85$0.80$0.75$0.70$0.76$0.73$0.71$0.74$0.79$0.80$0.80$0.79$0.76$0.70$0.70$0.73$0.73$0.70
High Forecast$1.08$1.06$1.08$1.03$1.02$0.98$1.01$0.96$0.92$0.89$0.87$0.81$0.87$0.82$0.77$0.72$0.79$0.73$0.71$0.74$0.79$0.80$0.80$0.79$0.76$0.70$0.70$0.73$0.73$0.70
Low Forecast$1.03$1.00$1.02$0.98$0.96$0.93$0.95$0.91$0.88$0.88$0.87$0.81$0.84$0.78$0.72$0.68$0.74$0.73$0.71$0.74$0.79$0.80$0.80$0.79$0.76$0.70$0.70$0.73$0.73$0.70
Surprise %-------------1.07%0.82%0.64%0.07%1.01%1.01%0.90%0.28%0.94%1.04%1.01%0.99%1.15%1.06%1.13%1.03%0.96%

According to 7 Wall Street analysts, Colgate-Palmolive Company's projected average Quarter EPS for Dec 23 is $0.85, with a low estimate of $0.84 and a high estimate of $0.87. This represents a -0.98% decrease compared to CL previous annual EPS of $0.86 (Sep 23).

Colgate-Palmolive Company Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ELEstée Lauder Companies$78.18$112.8344.32%Hold
ULUnilever$59.30$71.0019.73%Buy
KMBKimberly-Clark$131.14$155.6718.71%Hold
CLColgate-Palmolive Company$93.49$108.6716.24%Buy
PGProcter & Gamble Company$170.33$173.922.11%Buy
CHDChurch & Dwight$105.80$106.200.38%Hold
CLXClorox Company$163.32$147.00-9.99%Buy

CL Forecast FAQ

Is Colgate-Palmolive Company a good buy?

Yes, according to 19 Wall Street analysts, Colgate-Palmolive Company (CL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 12 'Buy' recommendations, accounting for 63.16% of CL's total ratings.

What is CL's price target?

Colgate-Palmolive Company (CL) average price target is $108.67 with a range of $100 to $121, implying a 16.95% from its last price of $92.92. The data is based on 19 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Colgate-Palmolive Company stock go up soon?

According to Wall Street analysts' prediction for CL stock, the company can go up by 16.95% (from the last price of $92.92 to the average price target of $108.67), up by 30.22% based on the highest stock price target, and up by 7.62% based on the lowest stock price target.

Can Colgate-Palmolive Company stock reach $140?

CL's average twelve months analyst stock price target of $108.67 does not support the claim that Colgate-Palmolive Company can reach $140 in the near future.

What are Colgate-Palmolive Company's analysts' financial forecasts?

Colgate-Palmolive Company's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $20.75B (high $21.17B, low $20.33B), average EBITDA is $5.09B (high $5.19B, low $4.99B), average net income is $3.17B (high $3.26B, low $3.09B), average SG&A $7.58B (high $7.73B, low $7.42B), and average EPS is $3.86 (high $3.97, low $3.75). CL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $21.55B (high $22B, low $21.08B), average EBITDA is $5.29B (high $5.4B, low $5.17B), average net income is $3.4B (high $3.5B, low $3.31B), average SG&A $7.87B (high $8.03B, low $7.7B), and average EPS is $4.14 (high $4.25, low $4.02).

Did the CL's actual financial results beat the analysts' financial forecasts?

Based on Colgate-Palmolive Company's last annual report (Dec 2022), the company's revenue was $17.97B, beating the average analysts forecast of $17.81B by 0.86%. Apple's EBITDA was $4.88B, beating the average prediction of $3.68B by 32.71%. The company's net income was $1.78B, missing the average estimation of $1.91B by -6.51%. Apple's SG&A was $6.56B, missing the average forecast of $6.58B by -0.21%. Lastly, the company's EPS was $2.13, missing the average prediction of $2.95 by -27.81%. In terms of the last quarterly report (Sep 2023), Colgate-Palmolive Company's revenue was $4.92B, beating the average analysts' forecast of $4.81B by 2.10%. The company's EBITDA was $1.03B, missing the average prediction of $1.18B by -12.87%. Colgate-Palmolive Company's net income was $708M, beating the average estimation of $659.5M by 7.35%. The company's SG&A was $1.82B, beating the average forecast of $1.76B by 3.65%. Lastly, the company's EPS was $0.86, beating the average prediction of $0.802 by 7.26%